137 related articles for article (PubMed ID: 37621059)
21. High-throughput quantitative assessments of the chemical complementarity of celiac disease related IGH CDR3s and a gliadin epitope.
Jain R; Bressler M; Chobrutskiy A; Chobrutskiy BI; Blanck G
Int Immunol; 2024 Apr; ():. PubMed ID: 38666722
[TBL] [Abstract][Full Text] [Related]
22. Profiling of the pattern of the human TRB/IGH-CDR3 repertoire in primary biliary cholangitis patients.
Han FF; Fang MX; Zhao DT; Dong YC; Yuan GH; Gao JE; Guo CL
Int Immunopharmacol; 2020 Jun; 83():106393. PubMed ID: 32353748
[TBL] [Abstract][Full Text] [Related]
23. Chemical complementarity between tumor resident, T-cell receptor CDR3s and MAGEA3/6 correlates with increased melanoma survival: Potential relevance to MAGE vaccine auto-reactivity.
Eakins RA; Chobrutskiy A; Teer JK; Patel DN; Hsiang M; Huda TI; Zaman S; Sexton WJ; Coppola D; Falasiri S; Blanck G; Chobrutskiy BI
Mol Immunol; 2022 Oct; 150():58-66. PubMed ID: 35987136
[TBL] [Abstract][Full Text] [Related]
24. Autoantibody recognition of an N-terminal epitope of hnRNP L marks the risk for developing HBV-related hepatocellular carcinoma.
Yau WY; Shih HC; Tsai MH; Sheu JC; Chen CH; Chow LP
J Proteomics; 2013 Dec; 94():346-58. PubMed ID: 24125732
[TBL] [Abstract][Full Text] [Related]
25. High-dose hepatitis B immunoglobulin therapy in hepatocellular carcinoma with hepatitis B virus-DNA/hepatitis B e antigen-positive patients after living donor liver transplantation.
Lee EC; Kim SH; Lee SD; Park H; Lee SA; Park SJ
World J Gastroenterol; 2016 Apr; 22(14):3803-12. PubMed ID: 27076765
[TBL] [Abstract][Full Text] [Related]
26. Antibodies elicited by naked DNA vaccination against the complementary-determining region 3 hypervariable region of immunoglobulin heavy chain idiotypic determinants of B-lymphoproliferative disorders specifically react with patients' tumor cells.
Rinaldi M; Ria F; Parrella P; Signori E; Serra A; Ciafrè SA; Vespignani I; Lazzari M; Farace MG; Saglio G; Fazio VM
Cancer Res; 2001 Feb; 61(4):1555-62. PubMed ID: 11245465
[TBL] [Abstract][Full Text] [Related]
27. miR-106b promotes cancer progression in hepatitis B virus-associated hepatocellular carcinoma.
Yen CS; Su ZR; Lee YP; Liu IT; Yen CJ
World J Gastroenterol; 2016 Jun; 22(22):5183-92. PubMed ID: 27298561
[TBL] [Abstract][Full Text] [Related]
28. The Correlation Between Hepatitis B Virus Precore/Core Mutations and the Progression of Severe Liver Disease.
Al-Qahtani AA; Al-Anazi MR; Nazir N; Abdo AA; Sanai FM; Al-Hamoudi WK; Alswat KA; Al-Ashgar HI; Khan MQ; Albenmousa A; El-Shamy A; Alanazi SK; Dela Cruz D; Bohol MFF; Al-Ahdal MN
Front Cell Infect Microbiol; 2018; 8():355. PubMed ID: 30406036
[TBL] [Abstract][Full Text] [Related]
29. Effects of antiviral therapy on long-term outcome after liver resection for hepatitis B virus-related hepatocellular carcinoma.
Urata Y; Kubo S; Takemura S; Uenishi T; Kodai S; Shinkawa H; Sakae M; Kaneda K; Ohata K; Nozawa A; Suehiro S
J Hepatobiliary Pancreat Sci; 2012 Nov; 19(6):685-96. PubMed ID: 22203455
[TBL] [Abstract][Full Text] [Related]
30. Peripheral immune characteristics of hepatitis B virus-related hepatocellular carcinoma.
Sun R; Li J; Lin X; Yang Y; Liu B; Lan T; Xiao S; Deng A; Yin Z; Xu Y; Xiang Z; Wu B
Front Immunol; 2023; 14():1079495. PubMed ID: 37077908
[TBL] [Abstract][Full Text] [Related]
31. Electrostatic Complementarities of Glioblastoma-Resident T-Cell Receptors and Cancer Testis Antigens Linked to Poor Outcomes and High Levels of Sphingosine Kinase-2 Expression.
Arias MA; Cios KJ; Kacsoh DB; Montgomery BE; Song JJ; Patel AR; Chobrutskiy A; Chobrutskiy BI; Blanck G
Biology (Basel); 2023 Apr; 12(4):. PubMed ID: 37106775
[TBL] [Abstract][Full Text] [Related]
32. Use of Expression Profiles of HBV-DNA Integrated Into Genomes of Hepatocellular Carcinoma Cells to Select T Cells for Immunotherapy.
Tan AT; Yang N; Lee Krishnamoorthy T; Oei V; Chua A; Zhao X; Tan HS; Chia A; Le Bert N; Low D; Tan HK; Kumar R; Irani FG; Ho ZZ; Zhang Q; Guccione E; Wai LE; Koh S; Hwang W; Chow WC; Bertoletti A
Gastroenterology; 2019 May; 156(6):1862-1876.e9. PubMed ID: 30711630
[TBL] [Abstract][Full Text] [Related]
33. A Bioinformatics Assessment Indicating Better Outcomes With Breast Cancer Resident, Immunoglobulin CDR3-MMP2 Binding.
Mandala SR; Thomson AJ; Gozlan EC; Patel DN; Chobrutskiy A; Chobrutskiy BI; Blanck G
Cancer Genomics Proteomics; 2023; 20(3):239-246. PubMed ID: 37093687
[TBL] [Abstract][Full Text] [Related]
34. Single-cell analysis reveals HBV-specific PD-1
Liu L; Liu J; Li P; Luo J; Qin R; Peng Q; Li B; Wei X; Wang T; Shi H; Wang MD; Li C; Fang W; Chen W; Xu X; Yang T; Yin W; Zeng X
J Exp Clin Cancer Res; 2023 Jun; 42(1):152. PubMed ID: 37353792
[TBL] [Abstract][Full Text] [Related]
35. Hepatitis B Virus-Associated Hepatocellular Carcinoma.
Rizzo GEM; Cabibbo G; Craxì A
Viruses; 2022 May; 14(5):. PubMed ID: 35632728
[TBL] [Abstract][Full Text] [Related]
36. Fine mapping of hepatitis B virus pre-S deletion and its association with hepatocellular carcinoma.
Kao JH; Liu CJ; Jow GM; Chen PJ; Chen DS; Chen BF
Liver Int; 2012 Oct; 32(9):1373-81. PubMed ID: 22676233
[TBL] [Abstract][Full Text] [Related]
37. Interleukin-24 Limits Tumor-Infiltrating T Helper 17 Cell Response in Patients with Hepatitis B Virus-Related Hepatocellular Carcinoma.
Zhang M; Zhao H; Gao H
Viral Immunol; 2022 Apr; 35(3):212-222. PubMed ID: 35099297
[TBL] [Abstract][Full Text] [Related]
38. Immunogenomics Parameters for Patient Stratification in Alzheimer's Disease.
Huda TI; Diaz MJ; Gozlan EC; Chobrutskiy A; Chobrutskiy BI; Blanck G
J Alzheimers Dis; 2022; 88(2):619-629. PubMed ID: 35662120
[TBL] [Abstract][Full Text] [Related]
39. Blood-Based Biomarkers in Hepatitis B Virus-Related Hepatocellular Carcinoma, Including the Viral Genome and Glycosylated Proteins.
Hayashi S; Nagaoka K; Tanaka Y
Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681709
[TBL] [Abstract][Full Text] [Related]
40. Gut microbiota dysbiosis with hepatitis B virus liver disease and association with immune response.
Yan F; Zhang Q; Shi K; Zhang Y; Zhu B; Bi Y; Wang X
Front Cell Infect Microbiol; 2023; 13():1152987. PubMed ID: 37201112
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
